Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

• Veronika Kremer,
• Maarten A. Ligtenberg,
• Rosa Zendehdel,
• Christina Seitz,
• Annet Duivenvoorden,
• Erik Wennerberg,
• Eugenia Colón,
• Ann-Helén Scherman-Plogell,
• Andreas Lundqvist

Affiliations

Veronika Kremer

Department of Oncology-Pathology, Karolinska Institutet

Maarten A. Ligtenberg

Department of Molecular Oncology, The Netherlands Cancer Institute

Rosa Zendehdel

Department of Oncology-Pathology, Karolinska Institutet

Christina Seitz

Department of Medicine Solna, Karolinska Institutet

Annet Duivenvoorden

Department of Oncology-Pathology, Karolinska Institutet

Erik Wennerberg

Department of Radiation Oncology, Weill Cornell Medicine

Eugenia Colón

Department of Oncology-Pathology, Stockholm South General Hospital

Ann-Helén Scherman-Plogell

Department of Urology, Stockholm South General Hospital

Andreas Lundqvist

Department of Oncology-Pathology, Karolinska Institutet